文献速递脑血管病

出血型烟雾病保守治疗的自然病程:复发出血与死亡风险

Natural Course of Moyamoya Disease in Patients With Prior Hemorrhagic Stroke.
PubMed 文献 · Stroke · 2019-01-01

本研究纳入128例保守治疗的出血型烟雾病患者,中位随访10.1年。随访期间36.7%的患者发生复发出血,平均年发生率4.5%,复发出血累积风险5年7.8%、10年22.6%、15年35.9%;吸烟是复发出血的独立危险因素,复发出血与高血压与死亡风险升高相关。

要点

  • 出血型烟雾病复发出血常见,是主要死亡原因,长期随访风险持续上升。
  • 复发出血累积风险5年7.8%、10年22.6%、15年35.9%,平均年发生率4.5%。
  • 吸烟与复发出血相关,高血压与死亡率升高相关,应重视危险因素管理。

核心结论

  • 出血型烟雾病患者复发出血常见且是主要死亡原因,长期随访中复发出血风险持续增加。
  • 吸烟是复发出血的独立危险因素,复发出血和高血压与死亡风险升高相关。

研究设计与样本

  • 回顾性纳入128例保守治疗且随访资料完整的出血型烟雾病患者。
  • 采用Kaplan-Meier生存分析计算出血年发生率和累积发生率,用logistic回归分析危险因素。

主要发现

  • 中位随访10.1(1-27)年,共1300.7患者年,47例(36.7%)发生59次复发出血,平均年发生率4.5%。
  • 复发出血患者中9例(19.1%)死亡,12例遗留严重残疾(改良Rankin量表评分≥3)。
  • 复发出血累积风险5年7.8%、10年22.6%、15年35.9%;仅4例(3.1%)发生缺血性卒中,平均年发生率0.3%。
  • 多因素分析显示吸烟是复发出血的独立危险因素(OR 4.85,P=0.04)。
  • 复发出血(HR 11.04,P=0.02)和高血压(HR 4.16,P=0.04)与死亡风险升高相关;年龄、初始出血类型、DSA分期、家族史及合并脑动脉瘤与复发出血风险无关。

临床怎么用

  • 对出血型烟雾病保守治疗患者应长期随访监测复发出血,并重视戒烟与血压管理。
  • 复发出血与高血压提示死亡风险升高,可作为临床风险评估与随访强度的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Evidence on the natural history of hemorrhagic moyamoya disease is still insufficient. We investigated the incidence of recurrent intracranial bleeding, mortality, and risk factors for rebleeding in patients with moyamoya disease. Methods- A total of 128 conservatively managed patients with hemorrhagic presentation and complete follow-up data were included. Recurrent hemorrhages during long-term follow-up were documented. Annual and cumulative incidence rate of bleeding was generated via Kaplan-Meier survival analysis, and risk factors were analyzed using logistic regression analysis. Results- The median follow-up time was 10.1 (1-27) years. During a total of 1300.7 patient-years, 47 (36.7%) patients experienced 59 occurrences of recurrent hemorrhages, rendering an average annual incidence of 4.5%. Among them, 9 patients (19.1%) died from rebleeding and 12 patients sustained severe disability (modified Rankin Scale score of ≥3). The cumulative risk of rebleeding was 7.8% at 5 years, 22.6% at 10 years, and 35.9% at 15 years. Only 4 (3.1%) patients experienced ischemic stroke, yielding an average annual incidence of 0.3%. Multivariate analysis showed that smoking (odds ratio, 4.85; P=0.04) was an independent risk factor of rebleeding. Rebleeding (hazard ratio, 11.04; P=0.02) and hypertension (hazard ratio, 4.16; P=0.04) were associated with increased mortality. Age, type of initial bleeding, digital subtraction angiography staging, family history, and coexisting cerebral aneurysms were not associated with increased risk of rebleeding. Conclusions- Rebleeding events were common and the main cause of death in patients with hemorrhagic moyamoya disease. The risk of rebleeding steadily increased during long-term follow-up. Smoking was a risk factor for rebleeding, and hypertension was associated with increased mortality.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kang S, Liu X, Zhang D, et al. Natural Course of Moyamoya Disease in Patients With Prior Hemorrhagic Stroke. Stroke. 2019. PMID: 30909836. doi:10.1161/STROKEAHA.118.022771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。